Karmanos Cancer Institute Welcomes New Physician to Enhance Cancer Care and Research
The Barbara Ann Karmanos Cancer Institute has recently expanded its multidisciplinary teams with the addition of Dr. Bradley Rockwell, a distinguished transplant hematologist. His expertise and extensive background in treating blood cancers are expected to contribute significantly to the institute's mission of battling malignancies such as leukemia, lymphoma, and multiple myeloma. Dr. Rockwell, who began treating patients at the Detroit location in July 2025, brings with him a wealth of knowledge and clinical experience from his prior roles.
Dr. Rockwell completed his postdoctoral fellowship at the Montefiore Medical Center and the Albert Einstein College of Medicine. His research there focused on innovative approaches to improving stem cell transplant efficacy, particularly through low-dose metronomic therapies that aim to reduce treatment-related toxicities. Moreover, he studied significant health outcomes in diverse populations, especially those affected by acute leukemia, which is critical in tailoring more effective treatments for varying demographics.
Expressing his enthusiasm about joining Karmanos, Dr. Rockwell remarked, "I am joining such an incredible and respected team of hematologists and transplant specialists at Karmanos, and I am thrilled to continue my life's work in Michigan. The program here is well-known across the country, and I am honored to continue to grow in my practice, giving patients the best quality care." His dedication aligns perfectly with the institute's commitment to raising care standards in the fight against cancer.
Karmanos Cancer Institute has established itself as a leader in transformative cancer care through research and education. As part of McLaren Health Care, it represents the largest resource of cancer care in Michigan. With a comprehensive cancer center designation from the National Cancer Institute, patients at Karmanos benefit from advanced treatment options and access to groundbreaking clinical trials. This setup allows for comprehensive care that extends beyond immediate treatment to long-term survivorship.
Dr. George Yoo, the Chief Medical Officer at Karmanos, acknowledged Dr. Rockwell's role in enhancing treatment outcomes. "Having physicians that push the standard of care needle forward is just what we need in the fight against cancer,” he said. Dr. Yoo emphasized that this approach not only enhances immediate patient care but also fuels future advancements in cancer therapies.
In addition to his research, Dr. Rockwell is also an assistant professor in the Oncology department at Wayne State University School of Medicine. This position enables him to contribute not only to treating patients but also to the education of future oncologists, thereby fostering a new generation of healthcare professionals dedicated to the fight against cancer.
To request an appointment with Dr. Rockwell or learn more about the services offered at Karmanos, patients can visit the institute's official website or call their dedicated appointment line. The Karmanos Cancer Institute remains steadfast in its mission to eradicate cancer and improve the quality of life for those affected by this disease. With each addition to their team, they continue to harness the capabilities of highly skilled professionals like Dr. Rockwell to advance cancer care.
With their focus on innovation, quality treatment, and compassionate care, Karmanos Cancer Institute reinforces its position at the forefront of cancer research and treatment in Michigan, dedicated to the vision of a future free from cancer.
Dr. Rockwell completed his postdoctoral fellowship at the Montefiore Medical Center and the Albert Einstein College of Medicine. His research there focused on innovative approaches to improving stem cell transplant efficacy, particularly through low-dose metronomic therapies that aim to reduce treatment-related toxicities. Moreover, he studied significant health outcomes in diverse populations, especially those affected by acute leukemia, which is critical in tailoring more effective treatments for varying demographics.
Expressing his enthusiasm about joining Karmanos, Dr. Rockwell remarked, "I am joining such an incredible and respected team of hematologists and transplant specialists at Karmanos, and I am thrilled to continue my life's work in Michigan. The program here is well-known across the country, and I am honored to continue to grow in my practice, giving patients the best quality care." His dedication aligns perfectly with the institute's commitment to raising care standards in the fight against cancer.
Karmanos Cancer Institute has established itself as a leader in transformative cancer care through research and education. As part of McLaren Health Care, it represents the largest resource of cancer care in Michigan. With a comprehensive cancer center designation from the National Cancer Institute, patients at Karmanos benefit from advanced treatment options and access to groundbreaking clinical trials. This setup allows for comprehensive care that extends beyond immediate treatment to long-term survivorship.
Dr. George Yoo, the Chief Medical Officer at Karmanos, acknowledged Dr. Rockwell's role in enhancing treatment outcomes. "Having physicians that push the standard of care needle forward is just what we need in the fight against cancer,” he said. Dr. Yoo emphasized that this approach not only enhances immediate patient care but also fuels future advancements in cancer therapies.
In addition to his research, Dr. Rockwell is also an assistant professor in the Oncology department at Wayne State University School of Medicine. This position enables him to contribute not only to treating patients but also to the education of future oncologists, thereby fostering a new generation of healthcare professionals dedicated to the fight against cancer.
To request an appointment with Dr. Rockwell or learn more about the services offered at Karmanos, patients can visit the institute's official website or call their dedicated appointment line. The Karmanos Cancer Institute remains steadfast in its mission to eradicate cancer and improve the quality of life for those affected by this disease. With each addition to their team, they continue to harness the capabilities of highly skilled professionals like Dr. Rockwell to advance cancer care.
With their focus on innovation, quality treatment, and compassionate care, Karmanos Cancer Institute reinforces its position at the forefront of cancer research and treatment in Michigan, dedicated to the vision of a future free from cancer.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.